EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

HPV16/18 Genotype and Histologic High-Grade Disease in Women with ASC-H Cytology: A Systematic Review of Genotype-Stratified Outcomes

Maria-Daniela Vasieș (Mazilu), Elena-Lavinia Rusu, Jasmina-Sorina Chiriac, Alexandra-Corina Faur, Elena-Rodica Heredea, Veronica-Daniela Chiriac

Diagnostics · 11.11.2026 · 16 (22) · 3727

DOI: 10.3390/diagnostics16223727 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diagnostics, online erschienen am 11.11.2026. Verfasst von Maria-Daniela Vasieș (Mazilu) und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Human papillomavirus (HPV) genotyping may stratify histologic risk among women with atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion (ASC-H). We evaluated genotype-specific high-grade outcomes.

Methods

PubMed and Europe PMC were searched on 1 October 2026 and updated on 7 October 2026. Two reviewers independently screened, extracted, and appraised studies in accordance with PRISMA 2020. Eligible English language studies provided ASC-H-specific histologic outcomes for HPV16/18-defined and comparator groups. Risk of bias was appraised with an adapted QUADAS-2 framework (the protocol-specified Joanna Briggs Institute prevalence checklist is reported in an appendix), and certainty was rated with GRADE. An exploratory restricted meta-analysis compared HPV16/18 with other high-risk HPV (hrHPV) for CIN2+/HSIL+ using random effects and modified Hartung–Knapp confidence intervals.

Results

Sixteen studies in 17 reports were included; six contributed 1655 women to the restricted comparison. The pooled risk ratio was 1.19 (95% confidence interval, 0.94–1.49), with substantial heterogeneity (I2 = 64.9%) and a prediction interval of 0.70–2.01. The results varied with study selection and genotype definition. In four studies with at least 30 hrHPV-negative women, high-grade outcomes occurred in 6.8–18.4%, and HPV-negative carcinomas were reported. Leave-one-out, screening context, and verification-restricted analyses did not show a consistent difference (histology in all participants: RR 1.01, 0.63–1.62). Incomplete verification, confounding by age and screening context, heterogeneous assays and populations, and inaccessible reports limited confidence; certainty was very low for both outcomes.

Conclusions

A modest relative difference between HPV16/18 and other hrHPV types cannot be excluded, but the pooled evidence does not demonstrate a consistent incremental risk difference. Other hrHPV types and negative hrHPV results do not exclude high-grade disease. These findings are consistent with current guidance for colposcopic evaluation of all ASC-H without genotype-based deferral.

Zitieren

APA

(Mazilu), M. V., Rusu, E., Chiriac, J., Faur, A., Heredea, E., & Chiriac, V. (2026). HPV16/18 Genotype and Histologic High-Grade Disease in Women with ASC-H Cytology: A Systematic Review of Genotype-Stratified Outcomes. Diagnostics, 16(22), 3727. https://doi.org/10.3390/diagnostics16223727

Vancouver

(Mazilu) MV, Rusu E, Chiriac J, Faur A, Heredea E, Chiriac V. HPV16/18 Genotype and Histologic High-Grade Disease in Women with ASC-H Cytology: A Systematic Review of Genotype-Stratified Outcomes. Diagnostics. 2026;16(22):3727. doi:10.3390/diagnostics16223727

BibTeX
@article{Mazilu2026,
  author = {(Mazilu), Maria-Daniela Vasieș and Rusu, Elena-Lavinia and Chiriac, Jasmina-Sorina and Faur, Alexandra-Corina and Heredea, Elena-Rodica and Chiriac, Veronica-Daniela},
  title = {HPV16/18 Genotype and Histologic High-Grade Disease in Women with ASC-H Cytology: A Systematic Review of Genotype-Stratified Outcomes},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3727},
  doi = {10.3390/diagnostics16223727}
}
Kostenlos starten →